Clinical and laboratory variables in the University of Ibadan, UIC, and Walk-PHaSST cohorts
| . | University of Ibadan, N = 249 . | UIC, N = 260 . | Walk-PHaSST, N = 387 . |
|---|---|---|---|
| Age, y | 19 (15-24) | 31 (23-42) | 35 (25-46) |
| Sex (female:male), % | 47:53 | 58:42 | 52:48 |
| Hydroxyurea therapy, n (%) | 7 (3) | 135 (52) | 160 (41) |
| BMI, kg/m2 | 19 (16-20) | 23 (21-26) | 23 (21-25) |
| Mean arterial pressure, mm Hg | 76 (70-82) | 86 (80-93) | 83 (78-90) |
| α-Thalassemia (α-/αα or α-/α-), n (%) | 106 (43) | 96 (37) | 125 (32) |
| BCL11A rs1427407 (G/T or T/T), n (%) | 116 (47) | 116 (45) | 159 (41) |
| . | University of Ibadan, N = 249 . | UIC, N = 260 . | Walk-PHaSST, N = 387 . |
|---|---|---|---|
| Age, y | 19 (15-24) | 31 (23-42) | 35 (25-46) |
| Sex (female:male), % | 47:53 | 58:42 | 52:48 |
| Hydroxyurea therapy, n (%) | 7 (3) | 135 (52) | 160 (41) |
| BMI, kg/m2 | 19 (16-20) | 23 (21-26) | 23 (21-25) |
| Mean arterial pressure, mm Hg | 76 (70-82) | 86 (80-93) | 83 (78-90) |
| α-Thalassemia (α-/αα or α-/α-), n (%) | 106 (43) | 96 (37) | 125 (32) |
| BCL11A rs1427407 (G/T or T/T), n (%) | 116 (47) | 116 (45) | 159 (41) |
Values are expressed as medians and IQRs.
BMI, body mass index.